Future Vaccine Growth Could Come From Recent Biotech Entrants – Tufts

The potential to create novel, innovative products has made the vaccine market more attractive in recent years, drawing new entrants as well as a resurgence of interest from traditional vaccine manufacturers, Tufts Center for the Study of Drug Development Director Kenneth Kaitin suggests